OLIDIA referencias disponibles en ALLPARA para uso profesional, de origen directo y certificadas en cada envío.
Olidia 120
Olidia 120 is an injectable, sterile absorbable poly-L-lactic acid (PLLA) dermal filler by PRP Life Science Co., Ltd. in South Korea, developed to temporarily improve moderate to severe nasolabial folds. It is suitable for practitioners treating these folds, with injection into the deep dermis or the subcutaneous (subdermal) layer. Each vial contains PLLA with carboxymethylcellulose (CMC) and mannitol at a total dose of 121.7 mg, and the product is intended for professional use.
Principales ventajas de Olidia 120
- Improves moderate to severe nasolabial folds
- PLLA-based formulation designed for a gradual tissue response after injection
- For professional injection into the deep dermis or subdermal layer
- CE-marked medical device (CE 1434)
Indicaciones y uso profesional
Indicaciones principales
- Moderate to severe nasolabial folds
Uso profesional
For professional use only, by trained physicians. Olidia 120 is administered by injection into the deep dermis or subdermal layer to temporarily improve moderate to severe nasolabial folds. Ensure the product is sterile before use and check the expiration date on the product label. Explain the indications, contraindications, and potential side effects to the patient prior to treatment. Avoid areas where vascular occlusion may occur; injection into blood vessels may cause serious effects including blindness, so avoid areas of thin skin and high vascularity such as the glabella and periorbital areas. Do not inject into the vermilion of the lips; safety and efficacy for lip augmentation are not established.
Zonas de tratamiento
- Moderate to severe nasolabial folds.
Perfil del paciente
Do not use until any infection or inflammation at or near the injection site is resolved. Do not use in patients hypersensitive to the product or its components. Safety has not been established in patients susceptible to keloids, hyperpigmentation, or hypertrophic scarring. In patients with a history of herpetic eruption, injection may trigger recurrence.
Cómo funciona Olidia 120
Olidia 120 works through poly-L-lactic acid (PLLA) combined with carboxymethylcellulose and mannitol. Injected into the deep dermis or subdermal layer, the PLLA stimulates a gradual tissue response to temporarily improve moderate to severe nasolabial folds.
Por qué comprar en Allpara
Allpara ofrece productos OLIDIA originales y verificados de proveedores seleccionados, con trazabilidad completa de lotes y asesoramiento experto. Atendemos a clínicas y profesionales de la estética con productos con certificado CE, entrega rápida en toda la UE desde nuestro almacén en la UE y precios profesionales competitivos. Nuestra prioridad es la seguridad, la satisfacción y los resultados de sus pacientes, con un servicio posventa dedicado para su tranquilidad.
Preguntas frecuentes
What is Olidia 120 used for?
Olidia 120 is used to temporarily improve moderate to severe nasolabial folds.
What is in the Olidia 120 formula?
Olidia 120 contains poly-L-lactic acid (PLLA) with carboxymethylcellulose (CMC) and mannitol, at a total dose of 121.7 mg per vial.
Where is Olidia 120 injected?
Olidia 120 is injected into the deep dermis or subdermal layer.
Más productos de PRP Life Science
Alternativas para la clínica
Retome donde lo dejó
Olidia 120
Olidia 120 is an injectable, sterile absorbable poly-L-lactic acid (PLLA) dermal filler by PRP Life Science Co., Ltd. in South Korea, developed to temporarily improve moderate to severe nasolabial folds. It is suitable for practitioners treating these folds, with injection into the deep dermis or the subcutaneous (subdermal) layer. Each vial contains PLLA with carboxymethylcellulose (CMC) and mannitol at a total dose of 121.7 mg, and the product is intended for professional use.
Principales ventajas de Olidia 120
- Improves moderate to severe nasolabial folds
- PLLA-based formulation designed for a gradual tissue response after injection
- For professional injection into the deep dermis or subdermal layer
- CE-marked medical device (CE 1434)
Indicaciones y uso profesional
Indicaciones principales
- Moderate to severe nasolabial folds
Uso profesional
For professional use only, by trained physicians. Olidia 120 is administered by injection into the deep dermis or subdermal layer to temporarily improve moderate to severe nasolabial folds. Ensure the product is sterile before use and check the expiration date on the product label. Explain the indications, contraindications, and potential side effects to the patient prior to treatment. Avoid areas where vascular occlusion may occur; injection into blood vessels may cause serious effects including blindness, so avoid areas of thin skin and high vascularity such as the glabella and periorbital areas. Do not inject into the vermilion of the lips; safety and efficacy for lip augmentation are not established.
Zonas de tratamiento
- Moderate to severe nasolabial folds.
Perfil del paciente
Do not use until any infection or inflammation at or near the injection site is resolved. Do not use in patients hypersensitive to the product or its components. Safety has not been established in patients susceptible to keloids, hyperpigmentation, or hypertrophic scarring. In patients with a history of herpetic eruption, injection may trigger recurrence.
Cómo funciona Olidia 120
Olidia 120 works through poly-L-lactic acid (PLLA) combined with carboxymethylcellulose and mannitol. Injected into the deep dermis or subdermal layer, the PLLA stimulates a gradual tissue response to temporarily improve moderate to severe nasolabial folds.
Por qué comprar en Allpara
Allpara ofrece productos OLIDIA originales y verificados, con trazabilidad completa de lotes, stock con certificado CE, entrega rápida en toda la UE y servicio posventa experto.
Preguntas frecuentes
What is Olidia 120 used for?
Olidia 120 is used to temporarily improve moderate to severe nasolabial folds.
What is in the Olidia 120 formula?
Olidia 120 contains poly-L-lactic acid (PLLA) with carboxymethylcellulose (CMC) and mannitol, at a total dose of 121.7 mg per vial.
Where is Olidia 120 injected?
Olidia 120 is injected into the deep dermis or subdermal layer.